NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Industry news » Contract Research Orgs back to previous page show list
TOP NEWS
Wuxi Pharma Tech
»23/10/2009 [Industry news]
WuXi PharmaTech appoints Dr Hui Cai as VP of Business Development

Dr Hui Cai has been appointed as Vice President of Business Development. She will report directly to Dr Richard M. Soll, Senior Vice President of Integrated Services.

 
WuXi PharmaTech, a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company with operations in China and the United States, has announced that Dr Hui Cai has been appointed as Vice President of Business Development. She will report directly to Dr Richard M. Soll, Senior Vice President of Integrated Services. Prior to joining WuXi, Dr Hui Cai was President of Inflexion BioPartners and Vice President of Corporate Development at HUYA Bioscience. Previously, Dr Cai spent ten years at Johnson & Johnson Pharmaceutical Research and Development on multiple small molecule drug discovery programs, and is co- author and co-inventor to over 40 scientific publications and issued or pending patents. Dr Cai was appointed by the Mayor of San Diego in 2002 as a Commissioner at City of San Diego Science and Technology Commission. She is Chair of the San Diego section of the American Chemical Society, and Chair of Board at SABPA (Sino-American Biomedical and Pharmaceutical Professionals Association). \"I am very pleased to welcome Ms Hui on board as we continue to enhance our business development,\" said Dr Ge Li, Chairman WuXi PharmaTech. \"She brings us a broad portfolio of expertise and experience in strategic planning, business development, and portfolio management, with which we are confident that our discovery business will grow rapidly.\"

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.